Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gut microbiota: A new therapeutic target for diabetic cardiomyopathy

26 Aug 2022

Abstract excerpt

Diabetic cardiomyopathy seriously affects quality of life and even threatens life safety of patients. The pathogenesis of diabetic cardiomyopathy is complex and multifactorial, and it is widely accepted that its mechanisms include oxidative stress, inflammation, insulin resistance, apoptosis, and autophagy. Some studies have shown that gut microbiota plays an important role in cardiovascular diseases. Gut...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Disease and Adiposity
Share to Cardiovascular Function and Risk Factors
Share to Diet and metabolism studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36091756
DOI: 10.3389/fphar.2022.963672

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gut microbiota: A new therapeutic target for diabetic cardiomyopathyPMID 36091756Read ↗

Gut microbiota in the pathogenesis and therapeutic approaches of diabetesSemantic proximity Read ↗

Metabolites of Gut Microbiota and Possible Implication in Development of Diabetes MellitusSemantic proximity Read ↗

Therapeutic applications of gut microbes in cardiometabolic diseases: current state and perspectivesSemantic proximity Read ↗

Novel Insights Into the Pathogenesis of Diabetic Cardiomyopathy and Pharmacological StrategiesSemantic proximity Read ↗

Diabetic cardiomyopathy: The role of microRNAs and long non-coding RNAsSemantic proximity Read ↗

Advancing lifelong precision medicine for cardiovascular diseases through gut microbiota modulationSemantic proximity Read ↗

Current Status and Potential Therapeutic Strategies for Using Non-coding RNA to Treat Diabetic CardiomyopathySemantic proximity Read ↗

Dysregulation of circulating miRNAs promotes the pathogenesis of diabetes-induced cardiomyopathy.Semantic proximity Read ↗

Gut Microbiota and Cardiovascular System: An Intricate Balance of Health and the Diseased StateSemantic proximity Read ↗

Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitusSemantic proximity Read ↗

Anti-diabetic treatment leads to changes in gut microbiomeSemantic proximity Read ↗

Gut microbiota and diabetes: from pathogenesis to therapeutic perspectiveSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.